COMPASS Pathways plc (CMPS)

COMPASS Pathways plc (CMPS) is a healthcare company (medical care facilities) based in the United Kingdom. The share price is $7.97, down 3.69% on the day, which values the company at $1.13B. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$7.97−3.69% today
Market value
$1.13B
200-week average
$7.496% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

COMPASS Pathways plc in more detail

CMPS trades at -5.5× next year's expected earnings. It sits 6% above its 200-week average of $7.49.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

2 of the superinvestors tracked here hold CMPS, including Cathie Wood (0.4% of the portfolio), Rob Citrone (0.1% of the portfolio).

Superinvestors holding CMPS

2 of the investors tracked here report a position in their latest 13F filing.

COMPASS Pathways plc (CMPS): questions and answers

What is COMPASS Pathways plc's market cap?

COMPASS Pathways plc is valued at $1.13B at a share price of $7.97.

Is CMPS above its 200-week moving average?

Yes. CMPS is 6.3% above its 200-week average of $7.49. Long-term investors watch that line because strong companies rarely trade below it for long.

Does CMPS pay a dividend?

COMPASS Pathways plc does not currently pay a regular dividend.

Which famous investors own CMPS?

In their latest quarterly filings, Cathie Wood (0.4% of the portfolio), Rob Citrone (0.1% of the portfolio) hold CMPS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “COMPASS Pathways plc (CMPS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CMPS

Underlying data: Yahoo Finance; company filings with the SEC.